Arkolith/Insider Trading/CTNM/Form 4

Lorrain Daniel S.

Chief Scientific OfficerContineum Therapeutics, Inc. (CTNM) · full profile →Form 4 · filed May 1, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$55K
Net Open-Market Flow
-$55K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 1, 2026Sell(S)4K$13.06$51K144K
May 1, 2026Sell(S)300$13.84$4K144K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-029435) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML